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Summary
Coats plus (CP) is a rare autosomal recessive disorder caused by mutations in CTC1,
a component of the CST (CTC1, STN1, and TEN1) complex important for telomere
length maintenance. The molecular basis of how CP mutations impact upon telom-
ere length remains unclear. The CP CTC1L1142H mutation has been previously
shown to disrupt telomere maintenance. In this study, we used CRISPR/Cas9 to
engineer this mutation into both alleles of HCT116 and RPE cells to demonstrate
that CTC1:STN1 interaction is required to repress telomerase activity. CTC1L1142H
interacts poorly with STN1, leading to telomerase-mediated telomere elongation.
Impaired interaction between CTC1L1142H:STN1 and DNA Pol-a results in increased
telomerase recruitment to telomeres and further telomere elongation, revealing that
C:S binding to DNA Pol-a is required to fully repress telomerase activity. CP CTC1
mutants that fail to interact with DNA Pol-a resulted in loss of C-strand mainte-
nance and catastrophic telomere shortening. Our findings place the CST complex as
an important regulator of both G-strand extensions by telomerase and C-strand syn-
thesis by DNA Pol-a.
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1 | INTRODUCTION
The development of aging phenotypes is associated increased accu-
mulation of damaged DNA in highly proliferative tissues, leading to
compromised tissue homeostasis and frailty. Increasing evidence
suggests that proper telomere function is critically important for the
maintenance of a stable genome. Telomeres, protein:DNA com-
plexes that cap the ends of chromosomes, play important roles in
preventing the activation of DNA damage checkpoints that would
otherwise induce cell cycle arrest and apoptosis. Mammalian telom-
eres consist of repeats of a TTAGGG lagging G-strand and the com-
plementary CCCTAA leading C-strand sequences that end in a
single-stranded (ss) G-rich overhang. Due to the inability of conven-
tional DNA polymerases to copy the lagging-strand of telomeric
DNA, progressive telomere shortening occurs with each round of
DNA replication in somatic cells. This “end replication problem” is
solved by the enzyme telomerase, a specialized ribonucleoprotein
complex that adds de novo telomere repeats to the 30 G-overhang.
Telomerase is normally expressed only in human stem and progeni-
tor cells. In somatic cells, the lack of telomerase expression results
in progressive telomere shortening and reduced cellular lifespan.
Consequently, overexpression of telomerase extends telomeres
maintains genome stability and prevents the onset of replicative
senescence.
Telomeres are bound by six telomere binding proteins, collec-
tively termed Shelterin, which cap and protect telomeres (Palm & de
Lange, 2008). The TTAGGG repeat binding factors, Telomere Recog-
nition Factor 1 (TRF1) and Telomere Recognition Factor 2: Repres-
sor/Activator binding Protein 1 (TRF2:RAP1), bind to the duplex
portion of telomeric DNA. The Protection of Telomere 1 (POT1) pro-
tein interacts with the ss telomeric overhang and forms a heterodi-
mer with TPP1 (a consensus name derived from the three competing
acronyms TINT1, PTOP, and PIP1), while TRF1-Interacting nuclear
protein 2 (TIN2), the linchpin of this complex, bridges TPP1:POT1
with TRF1:TRF2:RAP1 (Hu et al., 2017). Shelterin components func-
tion to repress distinct DNA damage response and repair pathways
at telomeres. For example, removal of TRF2 activates ATM to pro-
mote classical nonhomologous end joining (C-NHEJ)-mediated repair,
while removal of TPP1:POT1 activates ATR and telomere repair via
alternative (A)-NHEJ-mediated repair. Finally, RAP1 and TRF2 coor-
dinate to repress the activation of homology-directed DNA repair
(Denchi & de Lange, 2007; Guo et al., 2007; Rai, Chen, Lei & Chang,
2016; Rai et al., 2017).
In addition to telomere end protection, Shelterin cooperates with
multiple proteins to replicate telomeres. These proteins include the
evolutionarily conserved CTC1: STN1: TEN1 (CST) complex. CTC1
and STN1 were originally discovered as proteins that stimulate DNA
Pol-a: primase activity, suggesting an essential role for CST in DNA
replication (Casteel et al., 2009; Miyake et al., 2009; Surovtseva
et al., 2009). Targeted deletion of CTC1 in the mouse, as well as
depletion of individual CST components in human cells, all results in
telomere replication defects and global telomere attrition, suggesting
that the CST complex is required for multiple steps of telomere
replication (Feng, Hsu, Kasbek, Chaiken & Price, 2017; Gu et al.,
2012; Wu, Takai & de Lange, 2012). After DNA replication, leading-
strand telomeres are initially blunt-ended, requiring nucleolytic pro-
cessing of the leading-strand termini to generate the 30-overhang
needed for telomerase extension of the G-strand. In contrast, the
lagging-strand telomeres already possess a 30 G-overhang amenable
for telomerase extension. During S phase, TPP1 activates and stabi-
lizes telomerase on the G-overhang of both newly replicated leading-
and lagging-strand telomeres. However, telomere extension is
restrained by the CST complex (Chen, Redon & Lingner, 2012). The
recruitment of CST to telomeres, by POT1b in mouse cells and TPP1
in human cells, in turn promotes DNA Pol-a to perform C-strand fill-
in reactions (Wu et al., 2012). CST: DNA Pol-a-mediated C-strand
fill-in is absolutely required for telomere length maintenance, as
telomerase by itself is insufficient to generate the proper duplex
telomere (Feng et al., 2017; Gu et al., 2012). Defects in telomere
replication due to disruption of the CST complex lead to replication
fork stalling, as telomeres can adopt secondary structures that are
difficult to replicate (Gu et al., 2012; Stewart et al., 2012). Stalled
replication forks and the failure of stalled fork restart at telomeres
initiate aberrant homologous recombination events that in part
account for the catastrophic loss of total telomeric DNA observed in
mouse cells devoid of CTC1 (Gu et al., 2012), or the activation of a
DDR in mammalian cells (Wang et al., 2012).
Missense mutations in the human CTC1 gene cause Coats plus
(CP), a rare autosomal recessive disorder characterized by retinal
telangiectasia, intracranial calcifications, osteopenia, and gastroin-
testinal bleeding (Anderson et al., 2012; Polvi et al., 2012; Walne
et al., 2013). While some CP patients possess very short telomeres
and have phenotypes resembling those patients with Dyskeratosis
congenita (DC), suggesting that telomere maintenance is also func-
tionally impaired in these patients, telomere lengths in other CP
patients are not markedly reduced (Polvi et al., 2012). Biochemical
characterizations revealed that most human CP mutations disrupted
CST complex formation (Chen, Majerska & Lingner, 2013; Gu &
Chang, 2013). One mutation, CTC1L1142H, is particularly interesting
as it impacts on telomere length maintenance (Gu & Chang, 2013).
CTC1L1142 is a highly conserved amino acid at the C-terminus of the
protein that plays a role in promoting STN1 interaction (Chen et al.,
2013). As characterization of human disease mutations has often
yielded valuable insights into basic biological functions, we investi-
gated the impact of CTC1L1142H on telomere metabolism. We com-
pared the effect of this CTC1 mutation in two distinct cell types, the
HCT116 colon cancer cell line and the telomerase-immortalized reti-
nal pigment epithelial (RPE) cells. We show that mutant CTC1L1142H
interacts poorly with STN1 and that the CTC1:STN1 subcomplex is
sufficient to repress telomerase-mediated telomere elongation.
Expression of CP mutations that cannot interact with DNA Pol-a
show that CTC1:STN1 is also required to promote DNA Pol-a-
mediated C-strand maintenance. Our results reveal that the CST
complex is required to coordinate both telomerase-mediated G-
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strand extension and DNA Pol-a-mediated C-strand synthesis to
maintain telomere length homeostasis.
2 | RESULTS
2.1 | Characterization of cells expressing the
CTC1L1142H mutation
Coats plus patients are compound heterozygous for two different
CTC1 mutations, with one allele harboring a frameshift mutation
and the other a missense variant (Anderson et al., 2012; Keller
et al., 2012; Polvi et al., 2012; Walne et al., 2013). Previous analy-
sis of the human CTC1L1142H mutation relied on transient expres-
sion of the mutant in HT1080 cells bearing wild-type (WT) CTC1
alleles, making it difficult to understand the in vivo effects of this
mutation (Chen et al., 2013). To understand mechanistically how
the CTC1L1142H mutation impacted telomere metabolism in CP
patients, we utilized clustered, regularly interspaced, short palin-
dromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) to mutate
CTC1 Leu 1142 to His 1142 on both alleles in the HCT116 cell
line and telomerase-immortalized RPE cells (Figure 1a). A BseN1
restriction enzyme site was engineered into the targeted alleles to
facilitate screening for correctly targeted cells (Supplementary Fig-
ure S1a, b), and Sanger sequencing confirmed correct mutagenesis
(Supplementary Figure S1c). While CRISPR/Cas9-mediated mutage-
nesis was highly efficient in HCT116 cell lines and yielded several
correctly targeted clones, it was very difficult to generate
CTC1L1142H RPE mutants. We succeed in obtaining only one cor-
rectly targeted RPE CTC1L1142H mutant cell line (Figure 1b). Analy-
sis of two independently derived HCT116 CTC1L1142H clones
revealed that both grew at similar rates as the WT control and
expressed DNA Pol-a at similar levels (Figure 1b, c). Compared to
WT controls, the CTC1L1142H RPE clone R-46-5 exhibited slower
growth after the first seven passages in vitro (Figure 1b). This
reduced growth rate was likely not due to the activation of a
DNA damage response at telomeres in CTC1L1142H mutants, as we
did not observe a significantly increased localization of the DNA
damage signaling proteins c-H2AX and 53BP1 to telomere ends
over WT controls (Supplementary Figure S1d, e). Western analysis
showed that compared to WT controls, reduced STN1 level was
observed in both cell types bearing the CTC1L1142H mutation (Fig-
ure 1c). For both cell types, we attempted to detect the endoge-
nous CTC1L1142H mutant protein by immunofluorescence (IF)
microscopy. However, a reliable antibody against endogenous
CTC1 is not commercially available, and we were unsuccessful in
our multiple attempts to generate antibodies against both human
and mouse CTC1 (data not shown). To circumvent this difficulty,
we performed IF microscopy using an anti-STN1 antibody to visu-
alize endogenous STN1, which we have shown previously to be a
reliable marker to detect the endogenous CST complex (Gu et al.,
2012). We found that STN1 is present exclusively in the nuclei of
WT HCT116 cells, but in HCT116 CTC1L1142H mutants, nuclear
levels of STN1 are reduced (Figure 1d). Western analysis revealed
that endogenous STN1 is present at low levels and was barely
detectable in the nuclei of the RPE CTC1L1142H mutant (Fig-
ure 1d). Expression of Flag-CTC1L1142H revealed both nuclear and
cytoplasmic localization in HCT116 and RPE cells, suggesting that
STN1:CTC1L1142H interaction is unable to completely retain
CTC1L1142H to the nucleus (Figure 1e). Biochemical analyses
revealed that Flag-CTC1L1142H displayed reduced ability to interact
with both HA-STN1 and DNA Pol-a (Figure 1f). A DNA binding
assay revealed that in the presence of HA-STN1, Flag-CTC1L1142H
also bound poorly to single-stranded telomeric DNA (Tel-G:
TTAGGG4) (Figure 1f). Taken together, these results suggest that
the CTC1L1142H mutation disrupted interaction with STN1 and that
STN1:CTC1L1142H subcomplex cannot interact robustly with DNA
Pol-a or ss telomeric DNA, likely contributing to its partial localiza-
tion to the cytoplasm. In addition, endogenous DNA Pol-a levels
are significantly higher in HCT116 tumor cells than in immortalized
RPE cells.
2.2 | Increased telomere length in CTC1L1142H cells
We next examined telomere length in WT and CTC1L1142H mutant
cells continuously passaged in culture, using telomere restriction
fragment (TRF) Southern analysis and native in-gel DNA hybridiza-
tion with a CCCTAA (C-probe) oligonucleotide complementary to
TTAGGG to detect the 30-telomeric overhang repeats. Cells were
harvested at the indicated population doublings (PDs) and genomic
DNA prepared, digested with Hinf1/Rsa1 and resolved by gel elec-
trophoresis. After signal capture, the gel was denatured and rehy-
bridized with the C-probe to determine the amount of total
telomeric DNA present. An Alu probe was used as an internal
loading control. Surprisingly, compared to WT controls, both
HCT116 and RPE CTC1L1142H mutant cell lines exhibited signifi-
cant telomere length increases, from an average telomere length
of ~3.5 to ~9.1 kb (Figure 2a). Interestingly, the heterogeneous
telomere lengths normally observed in WT cells, ranging in size
from ~2 to ~6 kb, became more restricted in mutant cells, span-
ning in most cases from ~6.3 to ~9.5 kb. To determine the status
of the 30-overhang in these cells, we normalized the total telom-
eric signal with the 30-overhang signal. In addition, we also used
Exo I digestion to distinguish single-stranded (ss) telomeric G-over-
hang from internal regions of ss telomeric DNA. While no appre-
ciable increase in ss telomeric signal was detected in HCT116
CTC1L1142H mutant cell lines, the RPE CTC1L1142H mutant exhib-
ited an ~3.5-fold increase in ss telomeric DNA, largely stemming
from a 7-fold increase in Exo I-resistant telomeric DNA (Fig-
ure 2b–d). An increased amount of Exo I-resistant ss telomeric
DNA was also observed in HCT116 CTC1L1142H mutants over WT
control (Figure 2b and c). This increased accumulation of internal
stretches of ss telomeric DNA likely represented defects in lag-
ging-strand synthesis during DNA replication, as endogenous DNA
Pol-a is present at very low levels in CTC1L1142H RPE cells and
cannot be efficiently recruited by CTC1L1142H to telomeres
(Figure 1c, e).
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We next examined whether the elongated telomere lengths in
CTC1L1142H mutants remained stable during continuous passaging.
While telomere lengths decreased in WT HCT116 and RPE controls
after continuous serial passages in vitro for over 4 months, suggest-
ing that these cells possessed insufficient telomerase to maintain
bulk telomere lengths, telomere lengths in both HCT116 CTC1L1142H
mutant cell lines remain stably elevated after continuously passaging
for ~110 PD (Figure 2d). Interestingly, the RPE CTC1L1142H mutant
displaying slight telomere shortening after 34 PD, with increased
heterogeneity observed in both the ss overhang and total telomere
lengths by 53 PD (Figure 2d). These results suggest that CTC1, in
complex with STN1, negatively regulates telomere length. While the
CTC1L1142H mutation led to an initial increase in telomere length in
RPE cells, this increase in length cannot be stably maintained.
2.3 | CTC1 leucine 1142 limits telomerase-
mediated telomere elongation
To understand mechanistically how telomere lengths increased in
CTC1L1142H mutants, we reconstituted WT Flag-hCTC1 into WT and
mutant HCT116 cell lines. Expression of WT Flag-CTC1 increased
endogenous STN1 levels in CTC1L1142H cells, reinforcing the notion
that endogenous STN1 is unstable in the presence of the
CTC1L1142H mutant (Figure 3a). Expression of WT Flag-CTC1
decreased telomere length in HCT116 CTC1L1142H mutant cell lines,
in accord with previous observations that the CST complex normally
represses telomere elongation (Figure 3b) (Chen et al., 2012). In con-
trast, WT Flag-CTC1 had no impact on telomere length when
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F IGURE 1 Generation of the CTC1 L1142H mutation in HCT116 and RPE cells using CRISPR/Cas9. (a) Schematic of the guide sgRNA
utilized to mutate CTC1L1142 to CTC1H1142. Arrows indicate PCR primers used for genotyping. (b) NIH 3T3 assays were used to measure the
proliferative capacities of the indicated cell lines. (c) Expression pattern of endogenous DNA Pol-a and STN1 in the indicated cell lines
detected by western analysis. c-tubulin was used as a loading control. (d) Immuno-FISH analysis for endogenous STN1 (green) and telomeres
(red) in WT or L1142H mutant HCT116 or RPE cell lines. STN1 was visualized using an anti-STN1 antibody, telomeres visualized by
hybridization with a 50-Tam-OO-(CCCTAA)4-30 PNA probe, and nuclei visualized by 4,6-diamidino-2-phenylindole staining (DAPI; blue). (e)
Immunostaining for WT Flag-CTC1 or Flag-CTC1L1142H (green) expressed in HCT116 or RPE cells. Nuclei were stained with DAPI (in blue). (f)
Co-IP was used to determine the ability of WT Flag-CTC1 and Flag-CTC1L1142H mutant proteins to interact with HA-STN1, endogenous DNA
pol-a, and ss telomeric DNA [Tel-G oligo: (TTAGGG)3]
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is responsible for elongating telomeres in CTC1L1142H mutants, using
the telomerase inhibitor BIBR 1532. Treatment of both WT and
HCT116 CTC1L1142H cell lines with 10 lM BIBR 1532 resulted in
rapid telomere shortening, while stopping BIBR treatment reversed
this decline, resuming telomere elongation (Figure 3b). These results
reinforce our observations that the CTC1L1142H mutation is unable
to restrain telomerase activity on the telomeric G-strand, resulting in
telomere elongation.
Telomerase recruitment to telomeres requires interaction with
the oligosaccharide-oligonucleotide binding (OB)-fold domain of
TPP1 (Nandakumar & Cech, 2012; Zhong et al., 2012). To examine
whether expressing WT TPP1 in cells bearing the CTC1L1142H muta-
tion can lead to further extension of telomere length, we overex-
pressed WT TPP1, full length TPP1 bearing a single amino acid
deletion in the acidic loop of the TEL patch (K170D) which abro-
gated its ability to interact with telomerase (Bisht, Smith, Tesmer &
Nandakumar, 2016; Kocak et al., 2014; Nandakumar & Cech, 2012),
WT TPP1-OB-fold domain, or TPP1-OB-fold domain containing two
mutations that prevented association with telomerase (TPP1-OB-RR)
(Zhong et al., 2012), in WT or CTC1L1142H HCT116 cells (Figure 3c).
After selection, cells were passaged for 60 days and telomere length
was determined by TRF Southern. Expression of WT TPP1 resulted
in telomere elongation in WT cells, from an average length of ~3.5
to ~4.5 kb. In CTC1L1142H mutants, WT TPP further increased telom-
ere length from an already long baseline level of ~6.5 to ~9.5 kb
(Figure 3d). Telomere length did not increase further in both WT
and CTC1L1142H cells expressing TPP1-D170, revealing that telomere
length increase is due to TPP1-mediated recruitment of telomerase.
Compared to vector control, expression of WT TPP1-OB, but not
TPP1-OB-RR, led to rapid telomere shortening in both WT and
CTC1L1142H cell lines due to the competitive removal of telomerase
from telomeres (Zhong et al., 2012). These results suggest that the
CTC1L1142H mutation is unable to repress telomerase recruitment by
TPP10s OB-fold, resulting in further telomere elongation.
We next examined telomere lengths in telomerase-immortalized
RPE cells. TRF Southern reveal that R-46-5 mutant cells initially pos-
sessed long telomeres, but with increasing passages telomeres in this
cell line shortened to the length of WT RPE cells (Figure 2d). Treat-
ment of R-46-5 mutant cells with BIBR 1532 resulted in increased
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F IGURE 2 Increased telomere lengths in cells bearing the CTC1L1142H mutation. (a) TRF Southern analysis of the lengths of single-stranded
(ss) (top panel) and total telomeric DNA (bottom panel) in cells of the indicated genotypes. Numbers at the bottom indicate the number of
population doublings (PDs). (b) Telomere length analysis of single-stranded (ss) (top panel) and total telomere length (bottom panel) in cells of
the indicated genotypes either treated with (+) or without () ExoI. Alu was used as DNA loading control. (c) Quantification of the relative ss
G-rich telomere signal normalized to total telomeric signal in cells of the indicated genotypes, either untreated (top) or treated (bottom) with
Exo I. Values represent the mean from three independent experiments and error bars represent standard error of the mean (SEM). (d)
Telomere length analysis of single-stranded (ss) (top panel) and total telomere length (bottom panel) of cells of the indicated genotypes
subjected to long-term serial passaging. PD: population doublings. Alu was used as DNA loading control. Numbers in native gel refer to ratio
of overhang signal intensity to total telomere intensity
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overhang and total telomere length (Figure 3e). Telomere-FISH
revealed progressive increase in the percentage of sister chromatids
with greatly reduced or missing telomere signals, a phenomenon ter-
med sister telomere loss (STL), on metaphase spreads from late pas-
sage R-46-5 mutant cells, but not WT cells (Crabbe, Verdun,
Haggblom & Karlseder, 2004) (Figure 3f, g). Fragile telomeres, promi-
nent in CTC1 knockout mouse cells and suggestive of telomere
replicative defects, were not significantly increased above back-
ground levels in CTC1L1142H RPE mutants (data not shown) (Gu
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serially passaged WT RPE cells, sister telomere loss was infrequent
and did not significantly increase with serial passages. Importantly,
reconstitution of WT Flag-hCTC1 into R-46-5 mutant cells pre-
vented both progressive telomere shortening and sister telomere loss
(Figure 3e–g), indicating that the CTC1L1142H mutation directly con-
tributed to the observed defects in telomere length maintenance.
2.4 | Increased telomerase recruitment to
telomeres in CTC1L1142H mutants
To understand how the CTC1L1142H mutation promotes telomere
elongation, we performed telomerase FISH on WT and CTC1L1142H
mutant cell lines reconstituted with plasmids expressing hTERT (the
F IGURE 3 CTC1 L1142H promotes telomere elongation by telomerase. (a) Determination of the expression of WT Flag-CTC1 and
endogenous STN1 in the indicated cell lines by western analysis. (b) TRF Southern analysis of telomere length in WT or mutant HCT116 cells
reconstituted with either WT CTC1 or cultured in the presence of 10 lM of the telomerase inhibitor BIBR. Cells were first passaged for 120
PD, reconstituted with WT CTC1 or treated with BIBR, and maintained for another 120 PD. +/BIBR: cells were maintained in the presence
of 10 lM BIBR for 60 PD, then maintained for another 60 PD after discontinuing BIBR treatment. (C) Expression levels of WT TPP1,
TPP1Δ170 or TPP1-OBWT or OBRR (K166R; K167R mutations) in HCT116 cells by western analysis. (d) Analysis of total telomeric DNA in WT
or mutant HCT116 cells expressing either WT TPP1, TPP1Δ170 or TPP1-OBWT or OBRR. Cells expressed TPP1 constructs for 60 days before
undergoing telomere length analysis by TRF Southern. Alu was used as a DNA loading control. (e) Telomere length analysis of single-stranded
(ss) (top panel) and total telomere length (bottom panel) in cells of the indicated genotypes. PD: population doublings. +CTC1: WT CTC1 was
expressed for 120 days before the cells were harvested for telomere length analysis. +BIBR: cells were treated with 10 lM of the telomerase
inhibitor BIBR. Numbers in native gel refer to ratio of overhang signal intensity to total telomere intensity. (f) Metaphase spreads revealing
sister telomere loss in RPEL1142H cells at the indicated PD. White arrowheads point to STLs. In one experiment, WT CTC1 was expressed in
RPEL1142H cells at PD 54 and then passaged for an additional 74 PD. (g) Quantification of the percentage of sister telomere loss in WT RPE or














































































































































F IGURE 4 Increased telomerase recruitment to the telomeres of CTC1L1142H mutant cells. (a) RPE or HCT116 cells were infected with
retrovirus expressing hTERT and TPP1, then transiently transfected with hTR. Fluorescence in situ hybridization (FISH) was used to detect co-
localization of hTR (red) with telomeres (50-Tam-OO-(CCCTAA)4-30 PNA, green) in cells of the indicated genotypes. White arrows point to co-
localized hTR-telomere signals in nuclei. (b, c) Quantification of the percentage of hTR-positive foci on telomeres in RPE (b) or HCT116 (c)
cells. At least 100 nuclei possessing co-localized hTR signal on telomere were counted. (d) FISH was used to detect hTR foci (red), and
immunofluorescence with anti-Flag antibody was used to detect the Flag-CST complex (purple) and a rabbit anti-TRF2 antibody was used to
detect endogenous TRF2 (green). Telomerase recruitment to telomeres is indicated in the merge panel by yellow spots. (Magnification: 1009).
(e) Quantitation of the fraction of telomerase foci-containing cells transfected with indicated CST constructs that contained ≤5 (blue) or ≥6
(orange) hTR foci per nucleus. Number of nuclei scored: WT CTC1: 55 nuclei, mutant CTC1: 67 nuclei, telomerase alone: 66 nuclei
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catalytic component of telomerase), hTR (the RNA component of
telomerase), and WT TPP1 (Kocak et al., 2014; Nandakumar & Cech,
2012). While only 5–10% of WT RPE and HCT116 cells displayed
>3–5 hTR-positive foci per nuclei, ~40% of CTC1L1142H RPE cells
displayed >5 hTR-positive foci per nuclei. Similarly, ~40% of HCT116
CTC1L1142H cells displayed >3 hTR-positive foci per nuclei (Fig-
ures 4a–c, Supplementary Figure S2a, b). These results further sup-
port the notion that CTC1 represses telomerase localization to
telomeres and that the CTC1L1142H mutation alleviates this inhibi-
tion. We utilized a second approach to determine how the
CTC1L1142H mutation impacted telomerase recruitment to telomeres.
HeLa cells transiently transfected with plasmids encoding hTERT,
hTR, CTC1 (either WT or CTC1L1142H), WT STN1, and WT TEN1
were examined for telomerase recruitment to telomeres. A FISH
probe against hTR was used to label telomerase, and a 50-Tam-OO-
(CCCTAA)4-30 PNA probe was used to label telomeres. Under such
overexpression conditions, the total number of observed hTR foci in
the nucleus is a good indicator of the amount of telomerase recruit-
ment. This is because successful telomerase recruitment to telom-
eres results in telomerase foci at several telomeres while lack of
recruitment causes telomerase to reside in 1-2 Cajal bodies in the
nucleus. Only 22% of cells expressing WT CTC1 showed >6 hTR foci
in the nucleus (Figure 4d, e). In contrast, 80% of cells expressing the
CTC1L1142H mutant displayed >6 hTR-positive foci in the nucleus,
indicating increased telomerase localization to telomeres in the pres-
ence of the CTC1L1142H mutation.
2.5 | CTC1 interaction with both STN1 and DNA
Polymerase-a is needed to completely repress
telomerase-mediated telomere length elongation
The observation that telomerase-immortalized CTC1L1142H RPE cells
cannot maintain elongated telomere lengths over long passages and
that expression of WT CTC1 prevented further telomere loss (Fig-
ure 3), suggest that telomerase-mediated elongation of the G-strand
cannot fully maintain telomere lengths. We therefore examined how
the C-strand is maintained in CTC1L1142H mutant cells. Previous
research revealed that the CP mutations CTC1A227V and CTC1V259M
abolished CTC1 interaction with DNA Pol-a that also resulted in a
paradoxical extension of telomere length (Chen et al., 2013). To
understand how these CTC1 DNA Pol-a interaction domain muta-
tions impacted upon telomere length regulation, we generated
CTC1A227V, CTC1V259M and the CTC1A227V; V259M double mutant
and performed co-immunoprecipitation (Co-IP) experiments with
DNA pol-a (Figure 5a). While all three CTC1 mutants failed to inter-
act with DNA pol-a, they were still able to robustly bind to single-
stranded Tel-G DNA in the presence of STN1. We next expressed
WT CTC1, CTC1A227V, CTC1V259M, or CTC1A227V; V259M in WT or
CTC1L1142H mutant cell lines (Supplementary Figure S3a). Compared
to WT CTC1, expression of all three CTC1 DNA pol-a mutants lead
to an increase in both telomere length and G-overhang in both WT
and CTC1L1142H HCT116 cells (Figure 5b). Expression of CTC1 DNA
Pol-a mutants, but not WT CTC1, also resulted in their enhanced
localization to the nuclear periphery (Supplementary Figure S3b) and
increased localization of telomerase to telomeres (Figure 5c and d).
These results suggest that interaction of CTC1 with STN1 and DNA
Pol-a is required to fully repress telomerase activity.
As DNA Pol-a is required for telomeric C-strand fill-in, which is a
prerequisite for telomere length elongation, it is puzzling why
expressing CTC1 DNA Pol-a interaction domain mutants did not
induce telomere shortening. We surmised that this was due to the
presence of high levels of endogenous DNA Pol-a in HCT116 cells
(Figure 1c). We tested this hypothesis by expressing CTC1 mutants
unable to interact with DNA Pol-a in RPE cells possessing low levels
of endogenous DNA Pol-a. While a slight increase in telomere length
was observed when these mutants were expressed in CTC1L1142H
RPE cells, both the lengths of total telomeres and the 30-G-over-
hangs were extremely heterogeneous, suggesting a defect in DNA
Pol-a-mediated C-strand fill-in reaction (Figure 5b). It is important
that, expression of the CTC1A227V; V259M double mutant in WT RPE
cells led to dramatic telomere loss and the disappearance of the 30
overhang. In addition, a 2.5-fold increase in the number of STLs and
a 6-fold increase in the number of fragile telomeres, indicative of
telomere replication defects, were observed (Supplementary Fig-
ure S4a–c). We surmised that expression of the CTC1A227V; V259M
mutant severely disrupted the localization of endogenous DNA Pol-a
to the C-strand of telomeres. Coupled with the inability of telom-
erase to elongate telomeres due to the presence of endogenous WT
CTC1, catastrophic telomere shortening generated a phenotype rem-
iniscent to what was observed in CTC1 null mouse cells (Gu et al.,
2012).
2.6 | The CTC1-STN1-DNA Pol-a complex inhibits
telomerase recruitment to telomeres
The CTC1L1142H mutant interacts poorly with both STN1 and DNA
Pol-a and fails to bind ss telomeric DNA, suggesting that physical
interactions between CTC1, STN1, and DNA Pol-a are all required
to bind to ss telomeric DNA. To test this hypothesis, we examined
whether artificially tethering mutant Flag-CTC1L1142H to STN1 via a
flexible 10-amino acid linker could rescue CTC1L1142H’s interaction
with DNA Pol-a and ss telomeric DNA. The Flag-CTC1WT-linker-
STN1 protein interacted robustly with both DNA Pol-a and ss telom-
eric DNA (Figure 6a), completely localized to the nucleus (Figure 6b)
and functionally reduced telomere lengths in both WT and
CTC1L1142H HCT116 and RPE cells (Figure 6c). In addition, expres-
sion of the Flag-CTC1WT-linker-STN1 constructs reduced telomerase
accumulation on telomeres, as revealed by telomerase FISH (Fig-
ure 6d and e). In contrast, while tethering STN1 to Flag-CTC1L1142H
increased the expression levels of Flag-CTC1L1142H, the Flag-
CTC1L1142H-linker-STN1 construct was unable to interact with either
DNA Pol-a or ss telomeric DNA, and it still localized partially to the
cytoplasm (Figure 6a, b). Flag-CTC1L1142H-linker-STN1 also dramati-
cally reduced telomere lengths in both WT and CTC1L1142H RPE
cells, likely by functioning as a dominant negative to reduce endoge-
nous DNA Pol-a accumulation at telomeres (Figure 6c). These results
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suggest that CTC1 is required to directly interact with STN1 to form
a CTC1:STN1 (C:S) complex. C:S then interacts with DNA Pol-a to
enable stable binding to ss telomeric DNA, and this C:S:DNA Pol-a
complex is inhibitory to telomerase-mediated G-strand extension.
2.7 | TEN1 promotes CTC1:STN1:DNA Pol-a
complex formation
To examine the contribution of TEN1 to CST complex formation
with DNA Pol-a and ss telomeric DNA, we first expressed Flag-
CTC1, HA-STN1, and Myc-TEN1 in HEK293T cells and examined
their interactions by Co-IP. By itself, HA-STN1, but not Flag-CTC1
or Myc-TEN1, weakly interacted with endogenous DNA Pol-a (Fig-
ure 7a). Co-expressing all three C:S:T components together resulted
in robust binding to DNA Pol-a, although C:S and S:T also interacted
well with DNA Pol-a. The presence of Myc-TEN1 enhanced the
interaction between Flag-CTC1L1142H and HA-STN1, as well as com-
plex formation between Flag-CTC1L1142H, HA-STN1, and DNA Pol-a
(Figure 7b). TEN1 also promoted the interaction between Flag-
CTC1L1142H-linker-STN1 with endogenous DNA Pol-a and ss DNA
(compare Figures 6a to 7b). In addition, TEN1 also promoted the
interaction between Flag-CTC1L1142H, HA-STN1, DNA Pol-a, and ss
telomeric DNA. These results suggest that the trimeric CST complex
is required to efficiently interact with both DNA Pol-a and ss telom-
eric DNA.
3 | DISCUSSION
The CST complex has emerged as a negative regulator of telom-
erase-mediated telomere elongation (Chen et al., 2012). Deletion of
CTC1 results in extensive G-overhang extension due to increased
synthesis by telomerase. However, it is unclear how individual CST
components function to regulate telomere length. As the CST com-
plex also participates in a myriad of other biological activities at non-




























































































































































F IGURE 5 Disruption of CTC1:DNA Pol-a interaction results in further telomere elongation in CTC1L1142H mutant cells. (a) Biochemical
characterization of Flag-CTC1 WT and mutants unable to interact with endogenous DNA Pol-a. Flag-CTC1 was incubated with HA-STN1 and
interaction with endogenous DNA Pol-a was determined by Co-IP. (b) Analysis of the lengths of the 30 overhang (top panel) and total telomere
DNA (bottom panel) in HCT116 and RPE cells expressing WT CTC1, CTC1A227V, CTC1V259M, or CTC1A227V, V259M mutants for 2 months by
TRF Southern. Alu was used as a DNA loading control. (c) Expression of CTC1 mutants unable to interact with DNA Pol-a increased
telomerase recruitment to telomeres in CTC1L1142H mutant RPE cells. Cells of the indicated genotypes were infected with retrovirus
expressing hTERT and TPP1, then transiently transfected with a hTR cDNA. FISH was used to detect co-localization of hTR (red) with
telomeres (anti-TRF2 antibody, green). (d) Quantification of (c). For each cell type, a minimum of 100 nuclei with signal were scored for the
number of co-localized foci
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forks at GC rich loci (Chastain et al., 2016), we reasoned that delet-
ing individual CST components will likely lead to confounding effects
not associated with telomere length regulation. To circumvent this
issue, we used CRISPR/Cas9 to engineer the CTC1L1142H CP point
mutation into both alleles of HCT116 and RPE cell lines. This muta-
tion has been previously shown biochemically to reduce the interac-
tion between CTC1 and STN1 and to promote telomere elongation
(Chen et al., 2013; Gu & Chang, 2013). We provide functional evi-
dence that CTC1:STN1 is required to repress telomerase activity
in vivo. The CTC1L1142H protein interacts poorly with STN1 and
localizes partially to the cytoplasm, leading to telomerase-mediated
telomere elongation (Figure 7c). Biochemical characterization
revealed that CTC1L1142H, STN1, TEN1 interact poorly with both
DNA Pol-a and telomeric DNA, suggesting that the CTC1L1142H:
STN1:TEN1 complex cannot compete with telomerase for access to
the 30 G-rich overhang. Impaired interaction between CTC1L1142H:
STN1 and DNA Pol-a results in increased telomerase recruitment to
telomeres and further telomere elongation, revealing that C:S binding
to DNA Pol-a is required to fully repress telomerase activity. In addi-
tion, we also show that C:S regulates C-strand fill-in by DNA Pol-a.
Our findings place the CST complex as the major regulator of both
G-strand extension and C-strand fill-in reactions.
Deletion of CTC1 in both mouse and human cells results in















































































































































































DAPIFlag STN1(a) (b) (d)
(c)
(e)
F IGURE 6 The CTC1:STN1 complex inhibits telomerase recruitment to telomeres. (a) WT Flag-CTC1, Flag-CTC1L1142H, WT Flag-CTC1
tethered to STN1 or Flag-CTC1L1142H tethered to STN1 were examined for their ability to interact with HA-STN1, endogenous DNA Pol-a
and ss Tel-G oligo. (b) IF examination of the cellular distribution of WT Flag-CTC1, Flag-CTC1L1142H, WT Flag-CTC1-STN1, or Flag-
CTC1L1142H-STN1 in CTC1L1142H mutant RPE cells using anti-Flag antibody (green). Blue: DAPI staining to detect nuclei. (c) TRF Southern
analysis of telomere lengths in WT or CTC1L1142H mutant HCT116 or RPE cells expressing the indicated DNA constructs for 2 months. Alu
was used as DNA loading control. (d) Tethering CTC1L1142H to STN1 does not inhibit telomerase recruitment to telomeres in CTC1L1142H
mutant RPE cells. Cells of the indicated genotypes were infected with a retrovirus expressing hTERT and TPP1, then transiently transfected
with a hTR cDNA. FISH was used to detect co-localization of hTERC (red) with telomeres (anti-TRF2 antibody, green). (e) Quantification of (d).
A minimum of 100 nuclei for each cell type bearing hTR signals were scored for co-localization of telomerase with telomeres
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synthesis by telomerase and defects in C-strand fill-in synthesis by
DNA Pol-a, suggesting that the CST complex coordinates both of
these processes (Feng et al., 2017; Gu et al., 2012; Kasbek, Wang &
Price, 2013; Wan, Qin, Songyang & Liu, 2009). In vitro experiments
suggest that CST limits telomerase access to G-rich telomeric DNA
(Chen et al., 2012). Analysis of CTC1L1142H mutant cells revealed
that they possess elongated telomeres due to increased recruitment
of telomerase to telomeres. Artificially tethering CTC1L1142H to
STN1 was unable to prevent telomere elongation, indicating that
direct CTC1:STN1 interaction is required to impart negative regula-
tion to telomerase. Our data indicate that CTC1 binding to STN1
regulates telomerase access to the G-rich ss overhang and that
TEN1 is dispensable in this process.
Even with abundant telomerase, failure to maintain the C-strand
results in significant telomere shortening over time. Telomerase-
immortalized RPE cells bearing the CTC1L1142H mutation initially
exhibited a rapid increase in telomere length due to unrestrained
telomerase activity. However, telomeres did not remain stably
elongated, exhibiting progressive shortening after extensive passag-
ing, accompanied by increased heterogeneity of the 30 overhang.
Accumulation of internal ss G-rich telomeric DNA in CTC1L1142H
mutant cells suggests defective maintenance of the C-strand, which
is further exacerbated by the low level of endogenous DNA Pol-a
present in RPEs. Furthermore, our data suggest that C:S also regu-
lates C-strand maintenance by DNA Pol-a (Figure 7c). Both CTC1
and STN1 have been shown to interact with DNA Pol-a, with a
recent report suggesting that STN1 stimulates the switch between
RNA priming and DNA synthesis activities of DNA Pol-a (Ganduri &
Lue, 2017; Huang, Dai & Chai, 2012; Nakaoka, Nishiyama, Saito &
Ishikawa, 2012). Telomere shortening was further exacerbated with
the introduction of dominant negative CTC1 mutants incapable of
interacting with DNA Pol-a, leading to marked heterogeneity in the
length of the G-overhang and a smear of very long telomeres sug-
gestive of telomere hyperextension (Figure 6b). Defective C-strand
synthesis resulted in telomere loss manifested as STL. When
endogenous DNA Pol-a’s ability to interact with telomeres is further
(a) (b)
(c)
F IGURE 7 TEN1 enhances CTC1:STN1 interaction. (a) Biochemical characterization of Flag-CTC1, HA-STN1, and Myc-TEN1 interaction
with endogenous DNA Pol-a and ss Tel-G oligo. (b) Characterization of protein interactions between WT Flag-CTC1, Flag-CTC1 mutants, HA-
STN1, with (+) or without () Myc-TEN1, with endogenous DNA Pol-a and ss Tel-G oligo. (c) Summary of how WT and CTC1 mutants interact
with DNA Pol-a to influence telomere binding and telomere length maintenance
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compromised by expressing the dominant negative CP CTC1A227V;
V259M mutant that cannot bind to DNA Pol-a, total telomere loss
and the complete disappearance of the 30 G-overhang were
observed. In addition, elevated cytogenetic defects including STL
and fragile telomeres suggestive of telomere replication failure were
observed. This catastrophic telomere shortening phenotype is remi-
niscent of the dramatic loss of telomere sequences observed in
CTC1 null mice (Gu et al., 2012). Our data support a recent model
of telomere maintenance linking DNA replication to telomere length
regulation, with the CST complex regulating both G-strand exten-
sion by telomerase and C-strand fill-in by DNA pol-a (Greider,
2016).
Progressive telomere shortening was not observed in
CTC1L1142H mutant HCT116 tumor cells, revealing that C-strand fill-
in synthesis is not negatively impacted in this cancer cells due to
elevated levels of DNA Pol-a. Introduction of dominant negative
CTC1A227V; V259M mutant into the CTC1L1142H mutant background
resulted in further telomere elongation, suggesting that CTC1 (and
the CST complex) cooperates with DNA Pol-a to negatively regulate
telomerase. These findings are reminiscent of observations revealing
that disrupting the interactions between CDC13 and DNA Pol-a in
yeast and CTC1 and DNA Pol-a in mouse cells both result in telom-
ere elongation (Adams & Holm, 1996; Chen et al., 2013; Grossi,
Puglisi, Dmitriev, Lopes & Shore, 2004; Qi & Zakian, 2000). Our
data also highlight the significant differences in telomere length
maintenance mechanisms between normal and cancer cells. While
most investigations on telomere length maintenance mechanisms
focus on the impact of telomerase, our findings suggest that the
amount of endogenous DNA Pol-a is an equally important consider-
ation when evaluating telomere length maintenance mechanisms in
normal and cancer cells, a finding likely to have important implica-
tions in aging research.
Because a subset of CP patients displays markedly shortened
telomeres, this disease has been classified as a telomeropathy
(Armanios & Blackburn, 2012). However, unlike the classical telom-
ere shortening phenotype observed in DC patients, which is clearly
due to defects in telomerase, not all CP patients display short telom-
eres (Polvi et al., 2012). Moreover, CP patients display clinical mani-
festations distinct from those observed in DC patients, suggesting
that the underlying defects of these two diseases might be mecha-
nistically distinct. Results gleaned from overexpression studies of
human CP mutations in HCT116 cancer cells and expressing corre-
sponding human CTC1 mutations into CTC1/ MEFs strongly
suggest that CP is due to failure to properly maintain the telomeric
C-strand, leading to telomere replication defects (Chen et al., 2013;
Gu & Chang, 2013; Gu et al., 2012). STL is a prominent feature in
our late passage CTC1L1142H mutant RPE cell lines, and this cytoge-
netic aberration has been previously found in cells lacking the RecQ
helicase WRN, a protein necessary for the replication of G-rich
telomeric DNA (Crabbe et al., 2004). A recent report also suggests
that C-strand replication defects are associated with STLs (Takai
et al., 2016). We speculate that in tissues bearing an elevated level
of DNA Pol-a, the elongated telomeres exhibited by the CTC1L1142H
mutation likely conferred an initial proliferative advantage. However,
continuous cellular replication in tissues with limiting DNA Pol-a
levels results in C-strand maintenance defects, manifested as stalled
replication forks unable to bypass G-rich secondary structures
including G-quadruplexes (G4), resulting in the formation of single-
stranded gaps that when degraded give rise to STL. Both POT1 and
CST efficiently disrupt G-quadruplex formation in vitro (Bhattachar-
jee, Wang, Diao & Price, 2017; Wang, Nora, Ghodke & Opresko,
2011), and our data suggest that introduction of WT CTC1 into
CTC1L1142H mutants completely suppressed STL formation (Fig-
ure 3g). We postulate that CST/POT1 plays an important role in pre-
venting the formation of G4 on ss telomeric G-rich DNA to maintain
genome stability.
4 | EXPERIMENTAL PROCEDURES
4.1 | Plasmids and antibodies
CTC1 point mutations were generated by PCR. The fusion protein
CTC1-STN1 was linked by a 10 amino acids polyglycine spacer and
a Flag-tag was inserted at the N-terminus of CTC1. The retrovirus
vector pQXCIP (Clontech) was used for transient protein expression
in 293T cells or stable expression in the HCT116 and RPE human
cell lines. Antibodies that recognize phosphorylated cH2AX (Millipore
#05-636) and 53BP1 (Santa Cruz #sc-22760) were used for the
DNA damage assays. Mouse monoclonal anti-TRF2 (Millipore #05-
521) or rabbit polyclonal anti-TRF2 antibody (Novus NB110-5713)
was used to visualize telomeres for RNA-FISH. The anti-DNA Pol a
antibody was purchased from Santa Cruz (#sc-5921) and the anti-
STN1 antibody from Sigma (#WH0079991M1). Anti-epitope tag
antibodies were purchased from Sigma (anti-Flag #F3165 and anti-
HA #A300-305A) or Millipore (anti-Myc #05-724). The telomerase
inhibitor BIBR1532 was purchased from Sigma.
4.2 | Cell culture and the generation of CTC1-
L1142H mutant cell lines by CRISPR/Cas9
Human cancer HCT116 cells were maintained in McCoy’s 5A media
supplemented with 10% FBS. Human hTERT-immortalized RPE cells
were cultured in DMEM/F12 (1:1) media with 10% FBS. The CTC1-
L1142H point mutation targeting vector was constructed into rAAV-
vector GG-MCS-SEPT-N2 (Kan, Batada & Hendrickson, 2017) and a
new restriction enzyme site for BseNI was generated in the mutated
site. The sgRNA was inserted into lentivirus plasmid px458 (contain-
ing Cas9:GFP) and was designed so that it would likely destroy the
Hpy188III restriction enzyme recognition site around the mutation
site. The targeting vector and sgRNA plasmids were co-infected into
HCT116 or RPE cells and targeted cell lines were screened by BseNI
restriction enzyme digestion and further confirmed by DNA
sequencing. To over-express CTC1 wild-type or mutant protein in
HCT116 or RPE cells, the cells were infected by the relevant retro-
virus and then selected for puromycin resistance for at least one
week.
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4.3 | DNA binding and Co-IP assays
Streptavidin-sepharose beads (Invitrogen) coated with Biotin-Tel-G
(TTAGGG)6 were used for the ss DNA binding assays. Antibody
cross-linked-sepharose beads (Sigma) were used for Co-IP. Both
beads were incubated with crude cell lysates in TEB150 buffer
(50 mM Hepes, pH 7.3, 150 mM NaCl, 2 mM MgCl2, 5 mM EGTA,
0.5% Triton X-100, 10% glycerol and proteinase inhibitors) overnight
at 4°C. After washing with same buffer, the beads were analyzed by
immunoblot assay.
4.4 | Immunofluorescence–fluorescence in situ
hybridization
IF-FISH experiments for telomerase recruitment in super-telomerase
HeLa cells were performed as previously reported (Bisht et al., 2016)
with modifications to accommodate CST protein overexpression.
Confluent six-well plates containing HeLa cells were transfected with
a 2:1:1 ratio of CTC1:STN1:TEN1and a 3:1 ratio of hTR:hTERT using
lipofectamine 2000 (Life technologies) following manufacturer proto-
cols. The total DNA transfected per well was held constant by com-
plementation with empty vector if necessary and never exceeded
6 lg per well. Two days following transfection, cells were fixed with
4% formaldehyde in PBS for 10 min. Cells were washed with PBS
and then permeabilized in a solution containing 0.5% Triton X-100
and PBS. Following permeabilization, cells were blocked with PBS
containing 1 mg/ml BSA, 3% goat serum, 0.1% Triton X-100, 1 mM
EDTA (pH 8.0) for 1 h. After washing with PBS, the cells were incu-
bated with mouse monoclonal anti-FLAG M2 (Sigma; F1804; 1:500)
in combination with rabbit polyclonal anti-TRF2 antibody (Novus
NB110-5713; 1:200) for 30 min. Alexa Fluor 488-conjugated anti-
mouse IgG (Life Technologies) was used to detect FLAG-tagged CST
proteins by IF. Alexa Fluor 568-conjugated anti-rabbit IgG (Life
Technologies) was used to detect endogenous TRF2.
RNA-FISH assay in HCT116 or RPE cells was performed as fol-
low. Cells were infected with hTPP1ΔN, selected by puromycin, and
transiently transfected with hTR:hTERT at a ratio of 3:1 for 2 days.
Telomeres were visualized either by immunostaining with mouse
monoclonal anti-hTRF2 antibody and Alexa Fluor 488-conjugated
anti-mouse IgG (Life Technologies) or by mixing 50-Fam-OO-
(CCCTAA)4-30 probe with Cy5-conjugated TR probe.
4.5 | Metaphase PNA-FISH and
immunofluorescence (TIF) assays
To image metaphase spreads, cells were treated with 0.5 lg/ml of
colcemid for 4 hr before harvest. Trypsinized cells were treated with
0.06 M KCl, fixed with methanol:acetic acid (3:1) and metaphases
spread on glass slides. Metaphase spreads were hybridized with 50-
Tam-OO-(CCCTAA)4-30 probe. For the TIF assay, cells were seeded
in 8-well chambers and immunostained with primary antibodies
against c-H2AX or 53BP1, and then treated with FITC-secondary
antibodies before hybridization with the 50-Cy3-OO-(CCCTAA)4-30
probe to detect telomeres.
4.6 | TRF Southern
Serial cultures were performed according to the 3T3 protocol as pre-
viously described (Blasco et al., 1997). To analyze telomere length,
20 lg of total genomic DNA was separated by 0.8% agarose gel
electrophoresis. The gels were dried at 50°C and prehybridized at
55°C in Church mix (0.5 M NaH2PO4, pH 7.2, 7% SDS) and hybri-
dized with c-32P-(CCCTAA)4 oligonucleotide probes at 55°C over-
night. The gels were washed with 4 9 SSC, 0.1% SDS buffer at
55°C and exposed to phosphorimager screens. After in-gel hybridiza-
tion for the G-overhang under native conditions, the gels were dena-
tured with 0.5 N NaOH, 1.5 M NaCl solution and neutralized with
3 M NaCl, 0.5 M Tris-HCl, pH 7.0, then re-probed with c-32P-
(CCCTAA)4 oligonucleotide probes to detect total telomere DNA
after denaturation. Finally, the gel was re-denatured to remove all
probe and rehybridized with a c-32P radiolabeled Alu probe
(GTGATCCGCCCCGCCTCGGCCTCCCCAAAGTG) as an internal
loading control. To determine the relative G-overhang signals, the
signal intensity for each lane was scanned with a Typhoon imager
(GE) and quantified by ImageQuant (GE) before and after denatura-
tion. The G-overhang signal was normalized to the total telomeric
DNA and compared between samples.
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